R&D

Clinical Trials Round-Up: July/August 2026

While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.

News

Chemistry Nobel goes to molecular chirality researchers

The Nobel Prize in Chemistry 2026 has been awarded to Henri B Kagan and Kensō Soai for their discoveries in asymmetric organic synthesis.

News

AstraZeneca cuts ribbon on new R&D facility in Massachusetts

AstraZeneca's has opened a new R&D centre in the biotech hotspot of Cambridge, Massachusetts, the centrepiece of a $1bn investment in the state.

News

Nobel Prize in Physiology or Medicine winners 2026

Nobel Prize in Medicine awarded to optogenetics trio

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to optogenetics pioneers Karl Deisseroth, Peter Hegemann, and Georg Nagel.

R&D

Silhouette of a head with white brain under magnifying glass inside outline, against yellow background

Alzheimer’s: Starting the impossible journey

September was Alzheimer’s Month, and with that in mind pharmaphorum spoke to leaders at two biotechs about latest developments in the field.

News

Bayer names Christoph Koenen as its new CMO

Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.

Clinical Trials Round-Up: July/August 2026

Chemistry Nobel goes to molecular chirality researchers

AstraZeneca cuts ribbon on new R&D facility in Massachusetts

Nobel Prize in Medicine awarded to optogenetics trio

Alzheimer’s: Starting the impossible journey

Bayer names Christoph Koenen as its new CMO

Boosting biotech in Basel – with Valentina Francia

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks